Exhibit 99.1

 

JOINT FILING AGREEMENT

 

     In accordance with Rule 13d-1(k)(1) promulgated under the Securities Exchange Act of 1934, the undersigned agree to the joint filing of a Statement on Schedule 13G (including any and all amendments thereto) with respect to the Common Stock, $0.00001 par value per share, of PMV Pharmaceuticals, Inc. and further agree to the filing of this agreement as an exhibit thereto. In addition, each party to this Agreement expressly authorizes each other party to this Agreement to file on its behalf any and all amendments to such Statement on Schedule 13G.

 

Date: September 23, 2025 TANG CAPITAL PARTNERS, LP
 
 
  By:   Tang Capital Management, LLC    
  Its:   General Partner   
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   

 

  TANG CAPITAL PARTNERS INTERNATIONAL, LP
 
 
  By:   Tang Capital Management, LLC    
  Its:   General Partner   
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:    Manager  

 

  TANG CAPITAL PARTNERS III, INC
 
 
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:     Chief Executive Officer  

 

  TANG CAPITAL PARTNERS IV, INC
 
 
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:     Chief Executive Officer  


  TANG CAPITAL MANAGEMENT, LLC
 
     
  By:   /s/ Kevin Tang  
    Name:   Kevin Tang   
    Title:   Manager   
     
  /s/ Kevin Tang  
  Name:   Kevin Tang